This report analyzes global medicine use and spending trends through 2026, incorporating the ongoing effects of COVID-19. It projects global medicine market growth of 3–6% annually, driven by innovation and COVID-19 vaccines, while offset by patent expiries and biosimilars. Oncology and immunology remain the largest growth areas, while diabetes growth slows in developed markets. The report highlights disparities between developed and pharmerging markets, the impact of vaccination programs, and increasing reliance on specialty medicines. It emphasizes evidence-based policy decisions to balance access, affordability, and innovation in a post-pandemic world.

Join for free to read